11-101-2743
Clopidogrel Bisulfate Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™
Manufacturer: MilliporeSigma Supelco
CAS Number: 120202-66-6
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | 11-101-2743-Each-of-1 | In Stock | ₹ 23,051.00 |
11-101-2743 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 23,051.00
GST (18%): ₹ 4,149.18
Total Price: ₹ 27,200.18
CAS
120202-66-6
Type
Certified Reference Material
Linear Formula
C16H16 ClNO2 S · H2 SO4
Synonym
-Methyl (2-chlorophenyl)(6,7-dihydro-4 H-thieno[3,2-c]pyridin-5-yl)acetate hydrogensulfate
Grade
Certified Reference Material
Quantity
1 g
Purity Grade Notes
These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.
MDL Number
MFCD00876395
Formula Weight
419.90
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
Sigma Aldrich Fine Chemicals Biosciences Clopidogrel for system suitability European Pharmacopoeia (EP) Reference Standard | 120202-66-6 | MFCD00876395 | | -- | ₹ 24,531.07 | ||
Sigma Aldrich Fine Chemicals Biosciences Clopidogrel bisulfate United States Pharmacopeia (USP) Reference Standard | 120202-66-6 | MFCD00876395 | 125MG | -- | ₹ 2,05,296.30 | ||
Sigma Aldrich Fine Chemicals Biosciences Clopidogrel hydrogen sulfate European Pharmacopoeia (EP) Reference Standard | 120202-66-6 | MFCD00876395 | | -- | ₹ 16,899.32 | ||
Clopidogrel bisulfate | -- | ₹ 1,81,405.35 | ||
Clopidogrel hydrogen sulfate | -- | ₹ 14,169.93 | ||
Clopidogrel for system suitability | -- | ₹ 16,107.60 | ||
Clopidogrel hydrogen sulfate | -- | ₹ 1,869.00 - ₹ 27,590.00 | ||
120202-66-6 | sulfuric acid methyl (2S)-2-(2-chlorophenyl)-2-{4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl}acetate | -- | ₹ 534.00 - ₹ 24,030.00 |
Related Products
Description
- Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.Clopidogrel Bisulfate is a novel antiplatelet agent which is chemically related to ticlopidine
- It acts against ischaemic stroke, myocardial infraction as well as vascular disease
- It is reported to have exhibited clinical efficacy greater than that of aspirin, during large phase III trials
- Featured Industries: Pharmaceutical (small molecule)